FDA Drug recall D-0016-2014
HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL), Rx Only 4 mL INJECTABLE IM USE. Manufactured by Avella Specialty Pharmacy, Phoenix,…
- FDA Drug
- Class II
- terminated
- Published 2014-10-22
On 2014-10-22 the FDA classified a Class II recall of HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL), Rx Only 4 mL INJECTABLE IM USE. Manufactured by Avella Specialty Pharmacy, Phoenix,… by Avella, citing crystallization: Formation of crystals observed in product.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0016-2014 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2014-10-01 |
| Published | 2014-10-22 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Avella |
| Distribution | US |
Product
HYDROXYPROGESTERONE CAPROATE 250 MG/ML (IN SESAME OIL), Rx Only 4 mL INJECTABLE IM USE. Manufactured by Avella Specialty Pharmacy, Phoenix, AZ 85085.
Reason
Crystallization: Formation of crystals observed in product.
Identifiers
| code_info | Lot# 12-20140207@109; Exp. 12/14 Lot# 12-20142107@82; Exp. 01/15 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0016-2014%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.